Editor: What To Know
- The American Glaucoma Society Foundation also provides a platform for physicians, researchers and the USA Food and Drug Administration (FDA) to collaborate in the development of the regulatory science that guides the approval of new glaucoma diagnostic technologies and surgical devices.
- I am excited by the opportunity to join the Advisory Board and to actively contribute to discussions around research and education in glaucoma.
- The American Glaucoma Society is comprised of Glaucoma Specialists dedicated to sharing clinical and scientific information for the benefit of patients, colleagues, fellows and residents.
Joe Bankovich, President of Nova Eye, Inc., has been appointed as an industry representative to the American Glaucoma Society Foundation Advisory Board.
Established in 2011 and comprising over 1500 members, the American Glaucoma Society Foundation runs a number of programs to support glaucoma research and education. This includes programs designed to accelerate the advancement of glaucoma science and its translation into clinically important applications.
The American Glaucoma Society Foundation also provides a platform for physicians, researchers and the USA Food and Drug Administration (FDA) to collaborate in the development of the regulatory science that guides the approval of new glaucoma diagnostic technologies and surgical devices.
Joe Bankovich said, “The American Glaucoma Society Foundation is one of American ophthalmology’s premier subspecialty societies. I am excited by the opportunity to join the Advisory Board and to actively contribute to discussions around research and education in glaucoma. I am also humbled by the opportunity.”
The American Glaucoma Society is comprised of Glaucoma Specialists dedicated to sharing clinical and scientific information for the benefit of patients, colleagues, fellows and residents. Together with other health care organizations, the AGS serves as an important patient advocacy force to promote glaucoma awareness among policy makers and the general population.
